UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058577
Receipt number R000066899
Scientific Title Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue
Date of disclosure of the study information 2025/07/24
Last modified on 2025/07/24 10:54:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue

Acronym

Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue

Scientific Title

Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue

Scientific Title:Acronym

Effects of Branched-Chain Amino Acid Supplementation on Central Fatigue

Region

Japan


Condition

Condition

young healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to clarify whether branched-chain amino acids supplementation reduces subjective fatigue, task performance decline, and scores on subjective fatigue-related rating scales in young healthy individuals experiencing central fatigue induced by cognitive tasks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subjective Fatigue Symptoms Scale for Youth (SFS-Y)

Key secondary outcomes

subjective fatigue
cognitive task performance


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Participants will consume each of the following test beverages, which are widely available as general food products, once each. Fifteen minutes after ingestion, a 30-minute central fatigue-inducing task will be performed.
BCAA beverage: 2000 mg of branched-chain amino acids (BCAAs) in granule form dissolved in 200 mL of water.

Interventions/Control_2

Participants will consume each of the following test beverages, which are widely available as general food products, once each. Fifteen minutes after ingestion, a 30-minute central fatigue-inducing task will be performed.
Placebo beverage: A beverage with similar caloric content but without BCAAs, dissolved in 200 mL of water.

Interventions/Control_3

Participants will consume each of the following test beverages, which are widely available as general food products, once each. Fifteen minutes after ingestion, a 30-minute central fatigue-inducing task will be performed.
Water: 200 mL of natural mineral water.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >

Gender

Male and Female

Key inclusion criteria

1.Individuals aged 18 years or older and under 25 years, with no health problems.
2.Individuals who have received a full explanation of the study, sufficiently understood the contents, and voluntarily provided informed consent to participate.

Key exclusion criteria

1.Individuals with a history of allergies or other medical conditions related to dairy products.
2.Individuals with any current medical conditions under treatment.
3.Individuals who regularly take medications or supplements that may affect concentration.
4.Any other individuals deemed inappropriate as study participants by the principal investigator.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Sawada

Organization

Health Sciences University of Hokkaido

Division name

Department of Physical Therapy, School of Rehabilitation Sciences

Zip code

0610293

Address

1757, Kanazawa, Tobetsu, Hokkaido, Japan

TEL

0133-23-1310

Email

as-51@hoku-iryo-u.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Sawada

Organization

Health Sciences University of Hokkaido

Division name

Department of Physical Therapy, School of Rehabilitation Sciences

Zip code

0610293

Address

1757, Kanazawa, Tobetsu, Hokkaido, Japan

TEL

0133-23-1310

Homepage URL


Email

as-51@hoku-iryo-u.ac.jp


Sponsor or person

Institute

Health Sciences University of Hokkaido

Institute

Department

Personal name

Atsushi Sawada


Funding Source

Organization

Health Sciences University of Hokkaido

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethics Committee of School of Rehabilitaion Sciences, Health Sciences University of Hokkaido

Address

1757, Kanazawa, Tobetsu, Hokkaido, Japan

Tel

0133-23-1211

Email

kyo-reha@hoku-iryo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 07 Month 18 Day

Date of IRB

2025 Year 07 Month 24 Day

Anticipated trial start date

2025 Year 07 Month 24 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 24 Day

Last modified on

2025 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066899